-

Introducing National Exosome Day, Championed by (plated)™ Skin Science

As a leader in exosome innovation, (plated)™ Skin Science is on a mission to demystify the science of renewal and educate the world on the true potential of exosomes for skin and hair.

ROCHESTER, Minn.--(BUSINESS WIRE)--In recognition of the groundbreaking advancements in skin science, (plated)™ Skin Science is proud to announce the launch of National Exosome Day on April 8, 2025. This inaugural day is dedicated to raising awareness of exosome technology in aesthetics and its role in promoting healthier-looking, more radiant skin and hair.

Exosomes are tiny extracellular vesicles found in the body, packed with powerful nutrients like phosphopeptides and antioxidants. In skincare, exosome technology is designed to improve the look of aging skin and thinning hair by supporting the body’s natural ability to renew its appearance.

“The most transformative technologies are often invisible — yet their impact is undeniable,” says Dr. Daniel Gould, Beverly Hills board-certified plastic surgeon. “Exosomes are redefining what’s possible in skincare. Today is about sharing that vision and helping more people understand the science shaping the future of skin and hair care.”

“National Exosome Day is about recognizing a true breakthrough in skin science,” says Alisa Lask, CEO of Rion Aesthetics. “Exosomes are ushering in a new era — and we’re committed to leading the conversation with education, innovation, and purpose.”

About Rion Aesthetics

Rion Aesthetics, a regenerative aesthetics company founded in Rochester, MN and backed by over 15 years of visionary science, is at the forefront of platelet-derived exosome innovation, primarily focusing on investigational studies in hair restoration and facial wrinkle treatment. Additionally, in 2022, the company introduced (plated)™ Skin Science, an award-winning product line powered with Renewosome™ technology, designed to rejuvenate the skin's appearance and promote fuller-looking hair.

About (plated)™ Skin Science

(plated)™ Skin Science is an internationally recognized aesthetics product line, spearheading the industry's shift towards scientifically grounded and innovative exosome-based solutions to improve the appearance of the skin and hair. This versatile product line, featuring products for anti-aging, post-procedure recovery, and fuller-looking hair, is powered by Renewosome™ technology, an award-winning blend of platelet-derived exosomes with powerful antioxidants. For more information, please visit platedskinscience.com.

Contacts

Franco Botta at botta@rionax.com

Rion Aesthetics


Release Versions

Contacts

Franco Botta at botta@rionax.com

More News From Rion Aesthetics

The Fastest-Growing Professional-Grade Skincare Brand ( plated )® Skin Science to Spotlight Its Scientific Edge at TD Cowen Summit

ROCHESTER, Minn.--(BUSINESS WIRE)--( plated ) Skin Science, the fastest-growing professional-grade skincare brand developed by Rion Aesthetics, will participate in the TD Cowen Glowing Ahead Summit: Beauty’s Evolution & Longevity as Luxury, taking place February 23–25, 2026, in New York City. Alisa Lask, Chief Executive Officer & Founder of Rion Aesthetics, will participate in a panel on February 24, where she will discuss the rapid commercial acceleration of ( plated ) Skin Science, re...

Rapidly growing ( plated )™ Skin Science Expands U.S. Manufacturing with State-of-the-Art Facility to Meet Surging Demand

ROCHESTER, Minn.--(BUSINESS WIRE)--( plated )™ Skin Science, a breakthrough skincare brand powered by exosome science, today announced the opening of its new 14,000 square foot manufacturing facility in Rochester, Minnesota. Built to exclusively produce the brand’s proprietary platelet-derived exosomes, known as Renewosome™ technology, this expansion represents a major milestone as ( plated )™ responds to triple-digit growth in demand. Since launch, ( plated )™ has set a new standard for perfor...

Rion Aesthetics Supports Initiation of the First U.S. Investigator-Initiated Clinical Trial of Dermal Injections with PEP™ Exosomes

ROCHESTER, Minn.--(BUSINESS WIRE)--Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has allowed an Investigational New Drug (IND) application to proceed for a Phase 1 investigator-initiated trial evaluating Purified Exosome Product™ (PEP™) injected into the dermis. The study is sponsored and independently conducted by Clinical Testing Center of Beverly Hills and is being led by Dr. John H. Joseph, a...
Back to Newsroom